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Abstract: There is growing evidence that primary care prescribed antibiotics lead to 
antibiotic resistance in bacteria causing minor infections or being carried by asymptomatic 
adults, but little research to date has investigated links between primary care prescribed 
antibiotics and resistance among more serious infections requiring hospital care. 
Knowledge of these effects is likely to have a major influence on public expectations for, 
and primary care use of, antibiotics. This study aimed to assess the feasibility of recruiting 
symptomatic adult patients admitted to hospital with urinary infections and to link primary 
and secondary data information to investigate the relationship between primary care 
prescribed antibiotics and antimicrobial resistance in these patients. A microbiology 
database search of in patients who had submitted a urine sample identified 740 patients 
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who were potentially eligible to take part in the study. Of these, 262 patients did not meet 
the eligibility criteria, mainly due to use of a urinary catheter (40%). Two-hundred and 
forty three patients could not be recruited as the nurse was unable to visit the patients prior 
to discharge, as they were too unwell. Eighty patients provided complete information. 
Results indicate that there is evidence that prior antibiotic use is associated with resistant 
infections in hospital patients. A fully powered study, conducted using routinely collected 
data is proposed to fully clarify the precision of the association. 
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1. Introduction 
Resistance to antibiotics is a major threat to public health, and in the European Union, about  
25,000 patients die in hospital each year from infections caused by selected multidrug-resistant 
bacteria and the associated costs are estimated at about 1.5 billion Euros per year [1]. Of significant 
concern, is the rate at which bacteria are becoming resistant, which is outstripping the rate at which 
new antibiotics are being developed [2]. General Practitioners (GPs) are responsible for 80% of all 
antibiotics prescribed to humans [3]. Patient expectations for antibiotics are a powerful determinant of 
prescribing [4] and for some GPs and patients, antibiotic resistance is seen only as a theoretical [4] or 
minimal [5] risk. The relationship between primary care antibiotic prescribing and resistance is 
complex and incompletely understood. Previous studies have established the relationship between the 
use of antibiotics in primary care and the asymptomatic carriage of resistant bacteria in adults [6–8] 
and children [9]. A more recent systematic review [10] found 18 studies showing consistent, temporal 
relationships between prescribing and resistance in bacteria causing relatively minor infections and  
in asymptomatic subjects. These studies contribute important observations to the existing literature  
that improve our understanding of how antibiotic resistance develops [11], they may or may not be 
sufficient to persuade clinicians [12] or patients [13] of the value of judicious antibiotic use in relation 
to reducing antibiotic resistance among patients with symptomatic infections, especially those 
requiring secondary care treatment. 
Therefore, this paper reports a pilot and feasibility study, which aimed to investigate the 
relationship between primary care prescribed antibiotics and antimicrobial resistance, among 
symptomatic adult patients admitted to hospital with infection. Knowledge of these effects, and their 
associated economic impact, is likely to have a major influence on public expectations for, and primary 
care use of, antibiotics. 
The recently published European Strategic Action Plan on Antimicrobial Resistance called for 
research using links between primary and secondary care to reduce morbidity and mortality associated 
with antimicrobial resistance, to promote prudent use of antibiotics and to raise awareness of the 
emergence and spread of antimicrobial resistance across all healthcare settings [14]. The study aimed 
to use routinely collected data stored within the patient primary and secondary care record, and a key 
component of the study was to examine the feasibility of linking this information at the individual 
patient level. Specifically our objectives were to: determine optimal recruitment, consent and data 
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collection methods; describe the prevalence of antimicrobial susceptibility/resistance among isolated 
Escherichia coli (E. coli) from patients with urinary tract infection (UTI); and to examine primary care 
antibiotic prescribed within 12 months of admission and resistance to inform the sample size 
calculation of future studies. 
2. Results and Discussion 
Between October 2010 and July 2011, 6,783 urine samples were submitted for microbiology testing 
at UHBristol Trust laboratory. Of these, 2,147 grew an organism, of which 1,407 (65%) were ineligible 
(contaminant). The remaining 740 samples were from patients who were then potentially available to be 
screened for study eligibility (see Figure 1). Thirty-three female patients and twenty-five male patients 
could not be followed up due to lack of nurse time (n = 58). Thirty-eight percent of eligible patients 
were subsequently identified as ineligible and a further 36% could not meet with the research nurse as 
they were too unwell. Complete primary care data were available for 80 participants. 
Figure 1. Diagram showing flow of participants through the study. 
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2.1. Practices and Participants 
Patients were registered with a total of 25 GP practices with the majority of practices contributing 
one patient, and six practices having more than three patients recruited to the study. Mean (SD) 
participant age was 63.4 (20.1), with patient age ranging from 20–92 years. Sixty-four percent of the 
study cohort was female and 73% had been administered antibiotics in secondary care. The majority of 
these (86%) were given penicillin and/or trimethoprim (82%). Other characteristics of the study 
population are detailed in Table 1. 
Table 1. Characteristics of patient participating in study. 
Variable n(%) n = 105 
Age (mean(SD)) 63.4 (20.1) 
Age category 
20–49 
50–74 
75–84 
85+ 
- 
24(23) 
38(36) 
25(24) 
18(17) 
Female 67(64) 
Secondary care antibiotic use 
Trimethoprim 1 
Co-amoxiclav 1 
Amoxicillin 1 
Nitrofurantoin 1 
77(73) 
63(82) 
22(29) 
66(86) 
3(4) 
Visited hospital in previous 12 months 53(50) 
Antibiotic use in previous 12 months 
Yes 
Unknown 2 
- 
21(20) 
79(75) 
Co-morbidity 
Asthma 
Diabetes mellitus 
COPD 
History of smoking 
- 
14(13) 
16(15) 
3(3) 
46(44) 
1 Denominator = 77; 2 patient could not recall. 
Table 2 details the microbiology results for 105 recruited patients. E. coli was the most common 
organism. Thirty-three and 24 percent of urinary isolates tested were resistant to trimethoprim and 
amoxicillin respectively. 
Primary care data on antibiotic use was obtained for 63% (n = 80) of the recruited sample.  
Table 3 details the number of antibiotic used by patients in the previous 12 months. Thirty-seven 
percent of participants had no antibiotic prescriptions in the previous 12 months. Twenty-three percent 
of participants had three or more course of antibiotics prescribed in the previous 12 months. 
Unadjusted regression analysis showed that prescription of an antibiotic course in the previous 12 months 
was associated with presence of a urinary isolate resistant to trimethoprim (OR 3.58 95% CI 1.18 to 
10.9, Table 4). 
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Table 2. Organisms identified in patient urine samples. 
Organism identified n (%), n = 105 
Escherichia coli 75 (71) 
Proteus spp. 10 (10) 
Coliform 20 (19) 
Resistance (all urinary isolates) n = 105 
Trimethoprim 35 (33) 
Amoxicillin 25 (24) 
Ciprofloxacin 10 (10) 
Table 3. Primary care antibiotic courses in the previous 12 months. 
Antibiotic type n (%) n = 154 
a
 
Amoxicillin 
Co-amoxiclav 
Flucloxacillin 
Nitrofurantoin 
Trimethoprim 
Ciprofloxacin 
Erythromycin 
Clarithromycin 
Other 
20 (13) 
16 (10) 
13 (8) 
28 (18) 
31 (20) 
17 (11) 
15 (10) 
4 (3) 
10 (7) 
Number of courses n = 80 
0 
1 
2 
3–5 
6+ 
31 (39) 
22 (27) 
6 (8) 
12 (15) 
9 (11) 
a Number of courses prescribed n = 154 for n = 80 patients. Twenty-seven patients had more than one course 
of antibiotic prescribed in the previous 12 months. 
Table 4. Crude association between prescription of any antibiotic in the previous 12 months 
and trimethoprim resistance in patients admitted to hospital with suspected infection. 
Antibiotic prescribed n = 80 Resistant n = 25 (31%) Susceptible n = 55 (69%) Crude OR 95% CI 
Yes 49 (61) 20 (80%) 29 (53%) 3.58 
No 31 (39) 5 (20%) 26 (47%) 1.18 to 10.9 
2.2. Discussion 
This study has demonstrated that recruitment of patients in secondary care is feasible, but requires 
significant staff resources. Data linkage methods, once patient consent had been obtained, was a 
successful method of carrying out this research. Primary Care data was obtained from the GP practices 
and was facilitated by local Primary Care Research network support. Using ―opt-in‖ consent methods 
led to a high proportion (36%) of potentially eligible patients not being given the opportunity to 
participate in the study, and incomplete data where patients provided insufficient information on their 
GP practice. This has negative outcomes not only for the generalizability of the study findings but, 
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given that many of these patients were also too unwell to give consent, excludes patients suffering 
from more severe resistant infections. Furthermore, results of the pilot study showed that most patients 
were supportive of the research, with just two (0.3%) potentially eligible participants declined to take 
part in the research, as they were concerned about giving access to their medical records. This suggests 
that the opt-in consent method may not be the most scientifically robust or efficient method. Given that 
most of the data used in this study are routinely collected in primary and secondary care, with 
appropriate data security safeguards and regulatory approvals, this research could be conducted 
without any direct patient involvement. 
Results from a univariate analysis suggest that the primary care prescription of antibiotic in  
the 12 months prior to admission was associated with the presence of trimethoprim resistant isolates in 
patients admitted to hospital with UTI. This association appears clinically important, but needs to be 
adjusted for potential confounders (such as recent hospital admission) in future, more powerful, studies. 
In addition, in any future study sample size should be sufficient to allow for comparison between 
resistance to specific antibiotics. An important factor, which was identified in this study, is that 
resistance testing is not standardized within the secondary care setting. A further limitation of this 
study is that the primary reason for admission was unknown, reflected in the variety of antibiotic 
therapies recorded. This information should be included in a future study. A large proportion of the 
study sample was excluded as they had a urinary catheter, which threatens the generalizability of study 
findings. In a future fully powered study, the sample size should allow for subgroup analysis—for 
example, investigating the association between primary care antibiotic and resistance in patients who 
have a catheter or patients who have co-morbidities. 
Our pilot study produced results similar to those seen elsewhere. One Spanish study examined 
susceptibility to a number of antibiotics in patients treated by emergency services, who had been 
diagnosed with community acquired UTI. Patients who had been prescribed nalidixic acid or 
fluoroquinolones within the previous three months were found to have significantly higher resistance 
rates than those who had no previous primary care antibiotics [15]. A second study found that the odds 
of E. coli resistance to co-amoxiclav were four times higher comparing French patients hospitalized for 
urinary tract infection with and without co-amoxiclav exposure in the month prior to admission [16]. 
Finally, a cohort study retrospectively studied 24 adults with bacteraemic pneumonia (25 episodes) due 
to penicillin-resistant pneumococci compared with 48 patients with bacteraemic pneumonia caused by 
penicillin-sensitive pneumococci. The 24 patients with penicillin-resistant pneumococci had a 
significantly higher: incidence beta-lactam antibiotic use during the previous three months, 
hospitalization during the previous three months, nosocomial pneumonia and episodes of pneumonia 
during the previous year [17]. However, these studies are all relatively small and resistance rates vary 
substantially across Europe with Spain having higher rates than typically seen in the UK. 
2.3. Implications for Research and Clinical Practice 
Since much of the study data collected could have been collected from the microbiology database 
and the patient’s primary and secondary care records, database linkage methods might be more 
efficient for future studies. This would negate the need to recruit acutely unwell patients in the 
secondary care setting. Results from the study suggest that the decision to prescribe antibiotics in 
Antibiotics 2014, 3 35 
 
 
primary care can influence antibiotic resistance status in patients when they are admitted to secondary 
care, but needs to be confirmed in a fully adjusted, powered study. Further knowledge of association 
between primary care antibiotic prescribing and the development of resistant infections at an individual 
level will better inform shared GP-patient decision making in fully weighing up the pros and cons of 
prescribing and using antibiotics. This will benefit patients by discouraging the inappropriate 
prescription of antibiotics and help encourage the virtuous cycle of reduced antibiotic use and reduced 
bacterial resistance. 
3. Experimental 
3.1. Design, Setting and Participants 
The study was a controlled observational pilot study including adult patients being treated for a 
microbiologically confirmed urinary tract infection (UTI) at the University Hospital Bristol Trust. 
3.2. Identification of Bacteria 
The microbiology database was searched daily for samples submitted within 48 h of admission in 
which a bacterium was isolated. To be included urines had to have both: a significant positive culture 
and either a clinical descriptor for a urinary tract infection (cystitis or pyelonephritis) or positive  
ward-based urine dip stick result. In the laboratory, a positive leukocyte esterase, and a significant 
growth (104–105 or >105 cfu/mL) of a single or two organisms would be considered significant. Three 
or more organisms were regarded as contaminants and were excluded. 
3.3. Microbiology Methods 
Bacterial identification was based on appearance in chromogenic agar or by using the automated 
VITEK II system. Standard British Society for Antimicrobial Chemotherapy (BSAC) [18] disc testing 
methods were used to determine antibiotic resistance status for any bacterium isolated from patient 
sample within the UHBristol Trust laboratories. Disc testing methods were used to detect resistance to 
a variety of antibiotics. As we used data produced from standard NHS procedures not all samples were 
tested for resistance to the same antibiotics. 
3.4. Patient Recruitment and Consent 
The hospital’s microbiology database was searched to ascertain the location (which hospital ward  
or discharged) of patients in whom bacteria had been identified. The Research Nurse located each 
potentially eligible patient and asked permission from the patients’ clinical team to approach the 
patient to provide information about the study. Patients were asked to give consent for their primary 
and secondary care medical records to be used to extract study data. In addition, patients were asked to 
complete a brief baseline questionnaire giving details of: hospital visits in the previous 12 months; 
antibiotic use in the previous 12 months; co-morbidities; current medication and socio-demographic 
information. If patients had been discharged before the nurse had an opportunity to recruit then an 
invitation letter and study material was sent from the microbiology team to the patient by post. Patients 
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were ineligible if they had previously taken part in the study or had insufficient capacity to give 
informed consent, or if the sample had been obtained from a urinary catheter. If patients were: under 
18 years of age; immunocompromised or unable to read and understand English; they were also 
excluded Ethical approval was given to search the primary care notes of patients from Bristol, North 
Somerset or South Gloucester Primary Care Trusts regions. Therefore, patients who were outside that 
catchment area were excluded. 
3.5. Primary Care Antibiotic Data 
GPs were informed by letter of their patient’s participation in the study. GPs were asked to complete  
a proforma to collect computer recorded primary care antibiotic prescribing and consultations in  
the 12 months prior to admission and six weeks post hospital discharge. In particular, the type,  
the number of units (capsules, tablets or suspension volume) per dose, the strength per unit, the  
total number of units and the dosing instructions was be collected for all courses of prescribed 
systemic antibiotics. 
3.6. Outcome Measures 
The main outcome of the study was to determine optimal recruitment, consent and data collection 
methods. In addition, we aimed to describe the prevalence of antimicrobial susceptibility/resistance 
among bacteria isolated from urine samples. 
Summary statistics were used to describe recruitment and data attrition rates and demographics, 
antibiotic exposure and outcomes of individuals with susceptible and resistant bacteria. A separate 
binary variable was created to represent if an organism showed resistance to trimethoprim (Yes/No). 
Prior exposure to antibiotics in the 12 months before admission was recorded as a binary variable 
(Yes/No). 
The pilot study was designed to estimate crude strengths of association to inform the sample size 
calculation of a future, definitive study. A logistic regression model was used to estimate the 
unadjusted strength of association between prior primary care antibiotic exposure and antibiotic 
resistance in the study and measures of variability between antibiotic exposure and resistance [19]. 
4. Conclusions 
Our study has demonstrated an important possible relationship between primary care prescribed 
antibiotics and trimethoprim resistance in patients admitted to secondary care with UTI. This should be 
replicated in a fully powered study. We have also demonstrated that the recruitment methods are 
feasible, but that the study could be more efficiently conducted using routinely collected data. These 
data could be easily available for research purposes, enabling ongoing monitoring of resistant 
infections in hospitals. Improvements in database connections between healthcare settings could 
enable this information to be fed between primary care and secondary care clinicians—thereby leading 
to more appropriate antibiotic use both within primary and secondary health care settings. 
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